SUDx-Biotec Corporation
Quick and accurate virus testing using glycan nanotechnology
Kagoshima, Japan · Founded 2006
- Headquarters
- Kagoshima
- Employees
- 1–10
- Founded
- 2006
- Business Model
- B2B
- Website
- sudxbiotec.jp
About
SUDx-Biotec Corporation is a Japanese biotech company founded as a Kagoshima University-derived venture in 2006, specializing in rapid virus diagnostic testing using glycan nanotechnology. The company's proprietary SGNP (Sugar chain-based Glycan Nanoparticle) technology enables highly sensitive and rapid PCR-based detection of viruses including influenza, COVID-19, and other pathogens using saliva samples. SUDx-Biotec develops diagnostic kits for dental applications, infectious disease testing, veterinary diagnostics, and offers contract research services based on its core glycan nanotechnology platform.
Summary
SUDx-Biotec Corporation is a Biotech company based in Kagoshima, Japan, founded in 2006.
Tech & App Stack
6 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company